Clinical Trial Update: Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Ramipril on blood vessel inflammation in patients with atherosclerosis, coronary artery disease, and vasculitis; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease
• Vasculitis

Drugs mentioned

• Ramipril (ramipril)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Atherosclerosis, Coronary Disease | Phase 2 | Status: COMPLETED